Cargando…

Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)

BACKGROUND AND OBJECTIVES: Azithromycin was rapidly adopted as a repurposed drug to treat coronavirus disease 2019 (COVID-19) early in the pandemic. We aimed to evaluate its efficacy in patients hospitalised for COVID-19. METHODS: In a series of randomised, open-label, phase 2 proof-of-concept, mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gyselinck, Iwein, Liesenborghs, Laurens, Belmans, Ann, Engelen, Matthias M., Betrains, Albrecht, Van Thillo, Quentin, Nguyen, Pham Anh Hong, Goeminne, Pieter, Soenen, Ann-Catherine, De Maeyer, Nikolaas, Pilette, Charles, Papleux, Emmanuelle, Vanderhelst, Eef, Derweduwen, Aurélie, Alexander, Patrick, Bouckaert, Bernard, Martinot, Jean-Benoît, Decoster, Lynn, Vandeurzen, Kurt, Schildermans, Rob, Verhamme, Peter, Janssens, Wim, Vos, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801156/ https://www.ncbi.nlm.nih.gov/pubmed/35233389 http://dx.doi.org/10.1183/23120541.00610-2021

Ejemplares similares

Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma
por: Devos, Timothy, et al.
Publicado: (2022)

Modulation of thromboinflammation in hospitalized COVID‐19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn‐Antico study
por: Engelen, Matthias M., et al.
Publicado: (2022)

Rationale for azithromycin in COVID-19: an overview of existing evidence
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Remdesivir, on the road to DisCoVeRy
por: Gyselinck, Iwein, et al.
Publicado: (2022)

Chronic Obstructive Pulmonary Disease Exacerbations: Do All Roads Lead to Rome?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2022)

The stability of blood eosinophils in stable chronic obstructive pulmonary disease: a retrospective study in Belgian primary care
por: Van Rossem, Inès, et al.
Publicado: (2020)

Therapeutical strategies in cavitary legionnaires’ disease, two cases from the field and a systematic review
por: Moretti, Marco, et al.
Publicado: (2023)

A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study
por: Vanassche, T., et al.
Publicado: (2020)

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study
por: Vanassche, T., et al.
Publicado: (2020)

Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection
por: Smet, Jelle, et al.
Publicado: (2021)

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial
por: Vermeersch, Kristina, et al.
Publicado: (2019)

Estimating individual treatment effects on COPD exacerbations by causal machine learning on randomised controlled trials
por: Verstraete, Kenneth, et al.
Publicado: (2023)

Collaboration between explainable artificial intelligence and pulmonologists improves the accuracy of pulmonary function test interpretation
por: Das, Nilakash, et al.
Publicado: (2023)

Evolution of lung function and chest CT 6 months after COVID-19 pneumonia: Real-life data from a Belgian University Hospital
por: Stylemans, Dimitri, et al.
Publicado: (2021)

Can COPD Exacerbations Be Picked Up Early via a Weekly Medication Question Through a Smartphone Application?
por: Blondeel, Astrid, et al.
Publicado: (2022)

Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial
por: Liesenborghs, Laurens, et al.
Publicado: (2021)

Corrigendum to “itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens”
por: Liesenborghs, Laurens, et al.
Publicado: (2021)

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
por: Claes, Jorien, et al.
Publicado: (2015)

Cytomegalovirus: A Troll in the ICU? Overview of the Literature and Perspectives for the Future
por: Schildermans, Jolien, et al.
Publicado: (2020)

Diagnostic Approaches for Large Vessel Vasculitides
por: Betrains, Albrecht, et al.
Publicado: (2021)

The association of weather conditions with day-to-day variability in physical activity in patients with COPD
por: Blondeel, Astrid, et al.
Publicado: (2023)

Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial
por: Ockerman, Anna, et al.
Publicado: (2021)

Examining the Cross-Cultural Sensitivity of the Revised Two-Factor Study Process Questionnaire (R-SPQ-2F) and Validation of a Dutch Version
por: Stes, Ann, et al.
Publicado: (2013)

Principal component analysis of flow-volume curves in COPDGene to link spirometry with phenotypes of COPD
por: Verstraete, Kenneth, et al.
Publicado: (2023)

Patients’ acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: a CICERO Clinical Research Collaboration–European Lung Foundation online patient survey
por: Gyselinck, Iwein, et al.
Publicado: (2023)

P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation
por: Vincken, S., et al.
Publicado: (2022)

Screening in cryptogenic brain abscess: Do not forget pulmonary arteriovenous malformations
por: Rens, Jasmien, et al.
Publicado: (2021)

Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer
por: Smeets, Ann, et al.
Publicado: (2013)

Planned Pregnancy in a Chronic Myeloid Leukemia Patient in Molecular Remission
por: Pavlovsky, Carolina, et al.
Publicado: (2012)

Learning Is Better with the Hands Free: The Role of Posture in the Memory of Manipulable Objects
por: Dutriaux, Léo, et al.
Publicado: (2016)

Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients
por: Goeminne, Pieter Christian, et al.
Publicado: (2012)

Salute to the sun: a new dawn in yoga therapy for breast cancer
por: Galliford, Melissa, et al.
Publicado: (2017)

The Integration of Realistic Episodic Memories Relies on Different Working Memory Processes: Evidence from Virtual Navigation
por: Plancher, Gaën, et al.
Publicado: (2018)

Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections
por: Peetermans, Marijke, et al.
Publicado: (2014)

Circulating Interferon Production in the Mouse : Origin and nature of cells involved and influence of animal genotype
por: De Maeyer, Edward, et al.
Publicado: (1970)

Multiple oscillatory rhythms determine the temporal organization of perception
por: Ronconi, Luca, et al.
Publicado: (2017)

CoSMoMVPA: Multi-Modal Multivariate Pattern Analysis of Neuroimaging Data in Matlab/GNU Octave
por: Oosterhof, Nikolaas N., et al.
Publicado: (2016)

Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hcbbp6o7ql7id1p5j3j4jj629o